Evidence map›Paper›PMID 41551607›Full record

ArticleExtracellular vesicles and circulating nucleic acids2025

Tumor-targeted multifunctional extracellular vesicles as drug carriers for lung cancer therapy.

Narsireddy Amreddy, Akhil Srivastava, Natascha Riedinger, Murali Ragothaman, Yan D Zhao, Hariprasad Gali, Anupama Munshi, Rajagopal Ramesh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Extracellular vesicles and circulating nucleic acids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Narsireddy AmreddyDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Akhil SrivastavaDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Natascha RiedingerBoone Pickens School of Geology, Oklahoma State University, Stillwater, OK 74078, USA.
Murali RagothamanDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Yan D ZhaoOU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Hariprasad GaliOU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Anupama MunshiOU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Rajagopal RameshDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

Funding

Tissue Pathology Shared ResourceP30CA225520 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ROBERT S. MANNEL · 2018 to 2026
$27.1M
Exosomes as carriers of cancer therapeuticsR01CA254192 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI RAMESH, RAJAGOPAL · 2021 to 2025
$2.8M
Engineered Nanoformulation for Immune-modulation in CancerR01CA282735 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Rajagopal Ramesh · 2023 to 2026
$2.2M
NCI NIH HHS P30 CA225520NCI NIH HHS R01 CA254192NCI NIH HHS R01 CA282735
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chemotherapydrug deliveryExtracellular vesicleslung cancertumor targeting

Identifiers

PMID41551607
PMCPMC12809676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.